166 related articles for article (PubMed ID: 25636446)
1. High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.
Gao H; Guan M; Sun Z; Bai C
Tumour Biol; 2015 Feb; 36(2):515-20. PubMed ID: 25636446
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of c-Met in colorectal cancer: a meta-analysis.
Liu Y; Yu XF; Zou J; Luo ZH
World J Gastroenterol; 2015 Mar; 21(12):3706-10. PubMed ID: 25834339
[TBL] [Abstract][Full Text] [Related]
3. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
4. C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.
Yu S; Yu Y; Zhao N; Cui J; Li W; Liu T
PLoS One; 2013; 8(11):e79137. PubMed ID: 24223894
[TBL] [Abstract][Full Text] [Related]
5. ROCK I Has More Accurate Prognostic Value than MET in Predicting Patient Survival in Colorectal Cancer.
Li J; Bharadwaj SS; Guzman G; Vishnubhotla R; Glover SC
Anticancer Res; 2015 Jun; 35(6):3267-73. PubMed ID: 26026086
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
8. COX-2/C-MET/KRAS status-based prognostic nomogram for colorectal cancer: A multicenter cohort study.
Liu J; Huang C; Wang J; Huang L; Chen S
Saudi J Gastroenterol; 2019; 25(5):293-301. PubMed ID: 30720004
[TBL] [Abstract][Full Text] [Related]
9. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
10. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients.
Seo AN; Park KU; Choe G; Kim WH; Kim DW; Kang SB; Lee HS
Tumour Biol; 2015 Dec; 36(12):9813-21. PubMed ID: 26159851
[TBL] [Abstract][Full Text] [Related]
13. Prognostic roles of microRNA 143 and microRNA 145 in colorectal cancer: A meta-analysis.
Li C; Yan G; Yin L; Liu T; Li C; Wang L
Int J Biol Markers; 2019 Mar; 34(1):6-14. PubMed ID: 30854930
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis.
Peng J; Qi S; Wang P; Li W; Liu C; Li F
Dis Markers; 2016; 2016():6594016. PubMed ID: 27069297
[TBL] [Abstract][Full Text] [Related]
15. FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Personeni N; Rimassa L; Verusio C; Barni S; Rubino L; Bozzarelli S; Villa E; Carnaghi C; Tronconi MC; Gerardi C; Galli F; Floriani I; Destro A; Raschioni C; Labianca R; Santoro A
Clin Colorectal Cancer; 2015 Sep; 14(3):162-9. PubMed ID: 25861836
[TBL] [Abstract][Full Text] [Related]
16. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of c-Met and Notch-1 correlates with poor prognosis in resected non-small-cell lung cancer.
Wang X; Song N; Zhang Y; Cai Y; Liu Y; Qu X; Li Z; Li D; Hou K; Kang J; Hu X
Tumour Biol; 2015 Sep; 36(9):7053-9. PubMed ID: 25869878
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
